BNT165b1
- Generic Name
- BNT165b1
Safety and Immune Responses After Vaccination With an Investigational RNA-based Vaccine Against Malaria
- First Posted Date
- 2022-10-14
- Last Posted Date
- 2024-10-01
- Lead Sponsor
- BioNTech SE
- Target Recruit Count
- 60
- Registration Number
- NCT05581641
- Locations
- 🇺🇸
Alliance for Multispecialty Research, LLC, Knoxville, Tennessee, United States
🇺🇸University of Maryland, Center for Vaccine Development, Baltimore, Maryland, United States
🇺🇸Clinical Trials of Texas, Inc., San Antonio, Texas, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath